Molecular Assemblies, Inc.
Fully enzymatic DNA synthesis platform using engineered polymerases and enzymatic deblocking steps
- Sector
- Biotech
- Headquarters
- San Diego, CA
- Founded
- 2013
- Latest Form D
- $20.1M, Sep 2021
- Total capital
- $28.8M
- Federal grants
- $445K
- 2 awards · 2015–2021
- Rank in peer group#28 of 48
- Private capital raised
- $28.4M
- 4 Form D · last Sep 2021
- 61 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 16
- 24 pending · first 2016
- Rank in peer group#1 of 48
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 4th filing$20.1M
- Federal grantHealth and Human S · Phase I · Development of a Fully Enzymatic Oligonucleotide Synthesis Cycle by Engineered Template Independent Polymerases and a Novel Phosphate dNTP Blocking Group$256K
- Offering registeredForm D · SEC · 3rd filing$4.2M
- Private capital raisedForm D · SEC · 2nd filing$3.7M
- Private capital raisedForm D · SEC · 1st filing$4.5M
- Federal grantHealth and Human S · Phase I · Modified Nucleotidyl Transferases for Enzymatically Mediated Oligodeoxynucleotide Synthesis$189K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Federal first
24months
from Molecular Assemblies, Inc.’s first federal award to its first private round.
- First federal award · Aug 2015
- Health and Human S · $189K
- First Form D · Aug 2017
- $4.5M · 1st Form D
- Awards before first raise
- 1 award
An association in public records, not a cause or a prediction.
Standing among 48 peers
Line = medianBiotech · Platform
- Federal grantsBelow median
- Granted patents#1 · top 2%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Curt William BeckerExecutive Officer, DirectorNamed in SEC Form D filings
- David H. HwangDirectorNamed in SEC Form D filings
- Helge William BastianDirectorNamed in SEC Form D filings
- J. William Efcavitch, Ph.D.Director, Executive OfficerNamed in SEC Form D filings
- Jeffrey William Sampson, Ph.D.DirectorNamed in SEC Form D filings
- Joe H. SmithDirectorNamed in SEC Form D filings
Show all 11 people
- John William NicolsDirectorNamed in SEC Form D filings
- Larry William StambaughDirectorNamed in SEC Form D filings
- Michael J. KamdarExecutive Officer, DirectorNamed in SEC Form D filings
- Sean William FreemanExecutive Officer, DirectorNamed in SEC Form D filings
- Todd William PetersonDirectorNamed in SEC Form D filings
What it has protected
USPTO · 16 granted of 40- PendingMethods And Apparatus For Synthesizing Nucleic AcidsUSPTOApplication 18850185
- GrantedReusable Initiators For Synthesizing Nucleic AcidsUSPTOUS 12,168,211
- GrantedReusable Initiators For Synthesizing Nucleic AcidsUSPTOUS 12,152,265
Show all 40 patent records
- Methods And Apparatus For Synthesizing Nucleic AcidsJun 26, 2025 · Application 18850185Pending
- Reusable Initiators For Synthesizing Nucleic AcidsDec 17, 2024 · US 12,168,211Granted
- Reusable Initiators For Synthesizing Nucleic AcidsNov 26, 2024 · US 12,152,265Granted
- Layered Coding Architectures For Nucleic Acid MemoryOct 19, 2023 · Application 18042862Pending
- Homopolymer Encoded Nucleic Acid MemoryAug 24, 2023 · Application 18190319Pending
- Homopolymer Encoded Nucleic Acid MemoryMar 28, 2023 · US 11,612,873Granted
- Modified Template-independent Enzymes For Polydeoxynucleotide SynthesisJul 19, 2022 · US 11,390,858Granted
- Reusable Initiators For Synthesizing Nucleic AcidsJul 12, 2022 · US 11,384,377Granted
- Reusable Initiators For Synthesizing Nucleic AcidsMay 17, 2022 · US 11,331,643Granted
- Homopolymer Encoded Nucleic Acid MemoryNov 16, 2021 · US 11,174,512Granted
- Methods And Apparatus For Synthesizing Nucleic AcidsNov 4, 2021 · Application 17373314Pending
- Homopolymer Encoded Nucleic Acid MemoryApr 20, 2021 · US 10,982,276Granted
- Modified Template-independent Enzymes For Polydeoxynucleotide SynthesisSep 15, 2020 · US 10,774,316Granted
- Modified Template-independent Enzymes For Polydeoxynucleotide SynthesisSep 1, 2020 · US 10,760,063Granted
- Reusable Initiators For Synthesizing Nucleic AcidsJun 16, 2020 · US 10,683,536Granted
- Methods And Apparatus For Synthesizing Nucleic AcidsOct 25, 2018 · Application 16026662Pending
- Nucleic Acid Synthesis Using Dna Polymerase ThetaSep 27, 2018 · Application 15926642Pending
- Modified Template-independent Enzymes For Polydeoxynucleotide SynthesisAug 28, 2018 · US 10,059,929Granted
- Methods And Apparatus For Synthesizing Nucleic AcidsAug 7, 2018 · US 10,041,110Granted
- Methods And Apparatus For Synthesizing Nucleic AcidSep 26, 2017 · US 9,771,613Granted
- Methods And Apparatus For Synthesizing Nucleic AcidsJul 4, 2017 · US 9,695,470Granted
- Methods And Apparatus For Synthesizing Nucleic AcidsMar 8, 2016 · US 9,279,149Granted
- Homopolymer Encoded Nucleic Acid MemoryApplication PCTUS2020029780Pending
- Layered Coding Architectures For Nucleic Acid MemoryApplication 63069975Pending
- Homopolymer Encoded Nucleic Acid MemoryApplication PCTUS2018035365Pending
- Modified Template-independent Enzymes For Polydeoxynucleotide SynthesisApplication PCTUS2021035685Pending
- Nucleic Acid Synthesis Using Dna Polymerase ThetaApplication PCTUS2018023356Pending
- Layered Coding Architectures For Nucleic Acid MemoryApplication PCTUS2021047508Pending
- Homopolymer Encoded Nucleic Acid MemoryApplication 62513111Pending
- Nucleic Acid Synthesis Using Dna Polymerase ThetaApplication 62474426Pending
- Modified Template-independent Enzymes For Polydeoxynucleotide SysthesisApplication PCTUS2015056467Pending
- Methods And Apparatus For Synthesizing Nucleic AcidsApplication 63323766Pending
- Methods And Apparatus For Synthesizing Nucleic AcidsApplication PCTUS2023016226Pending
- Reusable Initiators For Synthesizing Nucleic AcidsApplication PCTUS2015045729Pending
- Methods And Apparatus For Synthesizing Nucleic AcidsApplication PCTUS2015045730Pending
- Methods And Materials For Synthesizing PolynucleotidesApplication 63520963Pending
- Reusable Initiators For Synthesizing Nucleic AcidsApplication 62069067Pending
- Modified Template-independent Enzymes For Polydeoxynucleotide SynthesisApplication 62065976Pending
- Methods And Apparatus For Synthesizing Nucleic AcidsApplication 62038604Pending
- Modified Template-independent Enzymes For Polydeoxynucleotide SynthesisApplication PCTUS2019057014Pending
Related companies, and why
- PEPTIDE LOGIC LLCSimilar federal contract value in Biotech · null in contracts
- Biomea Fusion, Inc.Similar federal contract value in Biotech · null in contracts
- Azitra Inc.Similar federal contract value in Biotech · null in contracts
- Cyrus Biotechnology, Inc.Similar federal contract value in Biotech · null in contracts
- POLARITYTE, INC.Similar federal contract value in Biotech · null in contracts
- Grace Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .